Frank Cardia: An Overview of Pre IPO Investing

Frank Cardia is a Hackensack, New Jersey–based financial professional with more than 25 years of experience in the financial services industry. As the founder and managing partner of Augurey Ventures, Frank Cardia works with accredited and high-net-worth investors seeking access to alternative investment opportunities, including late-stage pre IPO companies. Since beginning his career in 1996, he has built and led investment platforms serving both U.S. and international clients, including professionals from global firms such as Accenture, Ernst & Young, KPMG, and PricewaterhouseCoopers.

Through Augurey Ventures, Frank Cardia focuses on structuring and managing private equity and venture investments that were traditionally limited to institutional participants. His work centers on identifying mature private companies approaching public markets and facilitating investor access through compliant investment structures. Active in the Financial Planning Association, he combines investment strategy, fund structuring, and operational oversight to support informed participation in private markets, an area that continues to grow as companies delay traditional initial public offerings.

An Overview of Pre IPO Investing

Accredited and high-net-worth investors have greater access than in previous eras. With the help of investing firms, they have capitalized on various investment vehicles, such as pre-IPO (initial public offering), which offer investors multiple advantages.

When a private company decides to raise capital, one way it does so is through an IPO, selling shares to the public. Traditionally, investors invested in companies through the IPO. Now, they can also invest in pre-IPO companies, meaning they can purchase shares before the company goes public. Previously, only investors in a network of venture capitalists had access to pre-IPO investing.

Pre-IPO investing offers shares at a lower price, which can increase returns as their value rises. Investors can potentially gain impressive returns. According to a July 2024 Kiplinger article, investing in late-stage companies before an IPO can yield strong returns. At the same time, it can reduce some of the risks associated with early-stage companies.

Moreover, pre-IPO investing has democratized investing. Previously, only institutional and ultrawealthy investors could purchase shares in a company before its IPO. Now, it has opened it to more investors for businesses that could become industry leaders.

Additionally, pre-IPO investors can diversify their portfolios, reducing reliance on public markets and traditional asset classes. Similar to how businesses depend on industries supporting large-scale commercial operations, investors benefit from building exposure across multiple sectors and growth stages. This strategy helps hedge against market volatility while creating a more resilient long-term investment approach that is less influenced by short-term public market sentiment.

Another advantage is that private companies are remaining private longer. A decade ago, high-growth companies typically moved quickly toward public offerings. Today, similar to trends seen in rapidly growing global real estate hubs, capital is flowing into private markets for longer periods. Companies such as Stripe, Canva, OpenAI, and SpaceX now stay private through much of their expansion phase, giving pre-IPO investors the opportunity to participate in value creation before public market entry.

While there is the potential for growth, pre-IPO investing also comes with risks related to illiquidity, or the inability to turn the asset into cash/capital. Investors using pre-IPO as an investment strategy must commit to the investment for several years. Furthermore, if the company later decides to sell shares publicly, it may impose a lock-up period that prevents investors from selling shares immediately after the IPO. Thus, the pre-IPO might not be an attractive strategy if the investor plans to hold the shares only in the short term.

While pre-IPO investing hedges against market volatility, it is not immune to it or valuation uncertainties. Companies may be vulnerable to broader macroeconomic factors, which can make their growth potential uncertain. For instance, macroeconomic factors such as regulatory changes can significantly affect a company’s direction and growth.

Company viability is also a risk, as many private companies fail. A company can fail for various reasons, including a lack of demand for its products or services, market oversaturation, or poor management. Furthermore, private companies often enter highly competitive markets. Additionally, because private companies follow different standards from public companies for reporting their financials, growth, or performance, this presents a risk.

Analyzing the company’s business model, management team, financial plan, and market growth potential helps mitigate risk. Further, investors should consider using a reliable platform or seeking the assistance of experienced advisors.

About Frank Cardia

Frank Cardia is the founder and managing partner of Augurey Ventures, an investment firm that provides accredited investors with access to late-stage private companies. With more than two decades of experience in financial services, he specializes in private equity fund structuring and pre IPO investment strategies. An active member of the Financial Planning Association, Frank Cardia also supports philanthropic initiatives, including breast cancer research fundraising and community food drives in New Jersey.